Piaa farmaceutic din Romnia:

rezultate 2013 i perspective 2014

20 februarie 2014

Agenda
Rezultate 2013
Perspective 2014
Intrebri i rspunsuri

2
This document should not be distributed without Cegedim authorization Copyright 2011

01

Rezultate 2013

3
This document should not be distributed without Cegedim authorization Copyright 2011

Rezultate trim.4
VOLUM
Canal/
Segment

Cota
Pia
(%)

Total pia

ZILE DE
TRATAMENT

VALOARE PPP

Variaie
(+/- %)

Cota
Pia
(%)

Variaie
(+/- %)

Cota
Pia
(%)

100,0

-3,6

100,0

-1,1

100,0

3.055,8

-2,4

686,4

-0,8

Retail

95,1

-3,6

97,8

-0,9

86,2

2.634,1

-2,8

591,7

-1,2

- Rx

65,8

-4,4

85,9

-0,9

81,2

2.139,1

-4,2

480,5

-2,7

- OTC

34,2

-2,1

14,1

-0,7

18,8

495,0

4,0

111,2

5,7

Spital

4,9

-3,1

2,2

-9,3

13,8

421,7

0,3

94,7

1,9

RON
mil. RON (+/- %)

EUR
mil. EUR (+/- %)

4
This document should not be distributed without Cegedim authorization Copyright 2011

Rezultate 2013
VOLUM
Canal/
Segment

Cota
Pia
(%)

Total pia

ZILE DE
TRATAMENT

Variaie
(+/- %)

Cota
Pia
(%)

100,0

-1,1

Retail

95,1

- Rx

VALOARE PPP

Variaie
(+/- %)

Cota
Pia
(%)

RON
mil. RON (+/- %)

100,0

0,2

100,0

11.748,9

0,3

2.658,9

1,1

-1.0

97,8

0,4

86,6

10.168,8

0,4

2.301,3

1,3

67,6

-1,3

86,5

0,6

82,5

8.388,9

-0,8

1.898,5

0,1

- OTC

32,4

-0,2

13,5

-0,6

17,5

1.779,8

6,5

402,8

7,4

Spital

4,9

-3,1

2,2

-6,4

13,4

1.580,2

-0,5

357,6

0,4

EUR
mil. EUR (+/- %)

5
This document should not be distributed without Cegedim authorization Copyright 2011

Principalele grupe terapeutice (ATC1)

PRE
MEDIU

VOLUM

VALOARE PPP
Cota de
pia
(%)

Variaie
(+/- %)

11.748,9

100.0

0,3

23,1

10.056,7

85,6

1,4

1,2

17,3

2.115,5

18.0

-0,2

0,6

9,8

662,7

2.040,7

17,4

7,7

93,8

18,5

-1,5

18,9

1.775,0

15,1

4,5

N - Sistem Nervos

81,4

16,1

-2,4

18,8

1.533,6

13,1

-2,4

J - Anti-infecioase
Sistemice

40,3

8.0

-4,8

29,5

1.188,3

10,1

-0,7

R - Sistem Respirator

54,9

10,9

0,1

15.0

823,7

7.0

-2,4

M Sistem musculoscheletic

40,2

7,9

-1.0

14,4

579,9

4,9

-2,7

Alte grupe ATC1

69,6

13,8

-2.0

24,3

1.692,3

14,4

-5,6

Grupe ATC1

mil.
cutii

Cota de
pia (%)

Variaie
(+/- %)

RON

mil. RON

Total

505,8

100.0

-1,1

23,2

Top grupe ATC1

436,2

86,2

-0,9

122,5

24,2

3,1

C - Sistem
Cardiovascular
L - Antineoplazice si
Imunomodulatoare
A - Sistem Digestiv si
Metabolism

6
This document should not be distributed without Cegedim authorization Copyright 2011

Top 20 Corporaii
Nr.

Trim. 4
2013

Corporaie

Total pia
1
2
3
4
5
6
7

HOFFMANN LA ROCHE
SANOFI

1
2

NOVARTIS
SERVIER
PFIZER

GLAXOSMITHKLINE
MERCK & CO

Trim.3
2013

2013

(mil. RON)
3.055,8

(mil. RON)
11.748,9

(%)
100,0

214,6

860,1

7,3

+1

213,1

827,5

7.0

-1

175,7

697,3

5,9

173,6

677,7

5,8

151,8

604,4

5,1

143,7

552,6

4,7

113,3

468,9

4.0

RANBAXY

121.0

453,5

3,9

+1

ASTRAZENECA

113,9

444,2

3,8

-1

10

KRKA

80,8

311,8

2,7

1.501,5

5.897,9

50,2

74,7

295,6

2,5

76,2

288,2

2,5

Subtotal Top 10
11

ANTIBIOTICE
8

12

JOHNSON & JOHNSON

13

TEVA

69,6

272,3

2,3

14

ABBVIE

71,1

263,7

2,2

15

MENARINI

66,2

253.0

2,2

16

BRISTOL MYERS SQUIBB

56,6

227,2

1,9

60,1

223.0

1,9

+1

17

BAYER HEALTHCARE AG

18

ALVOGEN

53,4

213,6

1,8

-1

19

ABBOTT

10

46,6

185,4

1,6

20

ELI LILLY

47,1

185.0

1,6

2.123,1

8.304,7

70,7

Subtotal Top 20

7
This document should not be distributed without Cegedim authorization Copyright 2011

02

Perspective 2014

8
This document should not be distributed without Cegedim authorization Copyright 2011

Primele 20 grupe terapeutice (ATC3)

Secondary Sales
mil. RON
Growth
1 L1X (ALL OTHER ANTINEOPLASTIC)
1,041.5
21.0%
2 L4B (ANTI-TNF PRODUCTS)
470.3
18.4%
3 N5A (ANTIPSYCHOTICS)
468.2
10.7%
4 C10A (CHOLESTEROL AND TRIGLYCERIDE REGULATING PREPARATIONS) 425.7
5.8%
5 A10C (HUMAN INSULINS AND ANALOGUES)
413.4
13.2%
6 J5C (HIV ANTIVIRALS)
387.8
3.6%
7 L3B (INTERFERONS)
383.0
4.9%
8 M1A (ANTI-RHEUMATICS, NON-STEROIDAL)
348.5
7.4%
9 N2B (NON-NARCOTICS AND ANTI-PYRETICS)
318.1
12.1%
10 C9A (ACE INHIBITORS, PLAIN)
279.4
1.6%
11 A2B (ANTIULCERANTS)
245.7
10.8%
12 C4A (CEREBRAL AND PERIPHERAL VASOTHERAPEUTICS)
229.6
-4.2%
13 B1C (PLATELET AGGREGATION INHIBITORS)
226.7
-9.7%
14 R5A (COLD PREPARATIONS WITHOUT ANTI-INFECTIVES)
220.5
9.1%
15 N4A (ANTI-PARKINSON DRUGS)
217.9
22.8%
16 C7A (BETA-BLOCKING AGENTS, PLAIN)
206.6
10.0%
17 J5B (ANTIVIRALS, EXCLUDING ANTI-HIV PRODUCTS)
198.2
26.2%
18 J1D (CEPHALOSPORINS)
197.0
10.5%
19 C1D (CORONARY THERAPY EXCLUDING CALCIUM ANTAGONISTS AND NITRITES)
191.2
0.5%
20 J1C (BROAD SPECTRUM PENICILLINS)
190.4
5.4%
Subtotal Top 20 ATC3
6,659.7
10.0%
ATC3 Group

Tertiary Sales
mil. RON
Growth
712.3
9.9%
440.1
24.2%
333.6
-12.3%
339.3
-7.2%
365.4
1.1%
286.5
-2.2%
314.4
7.3%
292.5
-1.3%
266.2
-1.5%
251.0
-3.6%
218.0
5.3%
210.2
-7.0%
192.4
-17.2%
177.5
7.9%
208.9
15.6%
182.1
3.0%
159.2
7.5%
175.4
0.4%
172.8
-4.1%
156.8
-5.4%
5,454.5
1.4%

9
This document should not be distributed without Cegedim authorization Copyright 2011

Evoluie pe intervale valorice

Pret en-gros
2013
0: n/a

Unitati (mil.)
2012.0
1.0

% Pondere

2013.0
0.0

% Var

Valoare (mil. RON)

2,012.0

2012

2013

2013

0.3%

0.0%

-100.0%

26.5

2,013.0

% Pondere

% Var

2012

2013

2013

0.0

0.3%

0.0%

-100.0%

905.2

9.3%

9.1%

-3.0%

1: <10 RON

179.5

173.2 50.7%

49.6%

-3.5%

933.5

2: 10-25 RON

107.3

108.2 30.3%

31.0%

0.8%

1,760.6

1,740.4 17.5%

17.5%

-1.1%

3: 25-100 RON

53.5

55.5 15.1%

15.9%

3.7%

2,513.8

2,460.9 25.1%

24.7%

-2.1%

4: 100-250 RON

8.5

8.2

2.4%

2.4%

-3.6%

1,307.5

1,241.7 13.0%

12.5%

-5.0%

5: 250-1.000 RON

2.9

2.8

0.8%

0.8%

-3.2%

1,364.6

1,327.0 13.6%

13.3%

-2.7%

6: >1.000 RON

0.9

0.9

0.3%

0.3%

1.7%

2,125.8

2,282.6 21.2%

22.9%

7.4%

100.0%

-1.4%

10,032.2

9,957.9 100.0%

100.0%

-0.7%

Total

353.8

348.8 100.0%

10
This document should not be distributed without Cegedim authorization Copyright 2011

Disponibilitate alternative terapeutice

Nivel

Subcategorie

Produse noi
Produse existente
Produs
Produse disponibile
Produse iesite
Brand-uri noi
Brand-uri existente
Brand
Brand-uri disponibile
Brand-uri iesite
DCI/combinatii noi
DCI/combinatii existente
DCI
DCI/combinatii disponibile
DCI/combinatii iesite

2012

469
3,415
3,884
346
217
1,851
2,068
156
51
886
937
33

2013

452
3,606
4,058
284
203
1,936
2,139
135
37
882
919
53
11

This document should not be distributed without Cegedim authorization Copyright 2011

Perspective 2014
% Evolutie
Total Piata
Retail
Rx
OTC
Spital

2013
Prognoza

2013
Rezultat

2014

2015

2016

2017

2018

0.7%
1.3%
0.2%
6.6%
-2.9%

0.3%
0.4%
-0.8%
6.5%
-0.5%

2.7%
2.9%
2.5%
4.8%
1.5%

5.3%
5.5%
7.1%
-1.8%
4.1%

6.9%
6.6%
6.5%
7.1%
8.9%

6.3%
5.8%
5.4%
7.8%
9.3%

3.3%
3.0%
2.6%
5.0%
5.3%

Rata de Crestere Medie Compusa (CAGR) = 4,8%

12
This document should not be distributed without Cegedim authorization Copyright 2011

03

Intrebri i rspunsuri

13
This document should not be distributed without Cegedim authorization Copyright 2011

Intrebri i rspunsuri

Acum e rndul dvs

14
This document should not be distributed without Cegedim authorization Copyright 2011

Thank you for your attention

Email: petru.craciun@cegedim.com
www.cegedim.com